Brind.
  1. A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
  2. Amorfix received FDA Fast Track designation in Cambridge, MA.

Amorfix announced financing on July 28, 2025, from locations including Cambridge, MA and Toronto, Ontario.

1 report, 1 independent Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Amorfix announced financing on July 28, 2025, from locations including Cambridge, MA and Toronto, Ontario.

Who's involved

What this event is mainly about
Amorfix (Canada)Cambridge

Keep exploring

Part of

Amorfix received FDA Fast Track designation in Cambridge, MA. All 1 developments

Within A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireProMIS Neurosciences Announces Private Placement Financing $3 million private financing plus an additional $9 million of proceeds due to exercise of warrants, for gross proceeds of approximately $12.